Baird Medical Hosts Advanced Microwave Ablation Training with Top Thyroid Specialists
Baird Medical (NASDAQ: BDMD), a leader in Microwave Ablation (MWA) technology, hosted an advanced MWA training session in New Orleans. The program was led by Dr. Emad Kandil, Professor at Tulane University School of Medicine, training Dr. Shahzad Ahmad, an endocrinologist and thyroid specialist from Salt Lake City.
During the session, Dr. Ahmad, who serves as Treasurer of the North American Society of Interventional Endocrinology (NASOIE), observed four live MWA procedures and participated in hands-on training. The program concluded with discussions on implementing MWA across clinical settings and the awarding of a Certificate of Completion.
Baird Medical (NASDAQ: BDMD), leader nella tecnologia di Ablazione a Microonde (MWA), ha organizzato una sessione avanzata di formazione MWA a New Orleans. Il programma è stato condotto dal Dr. Emad Kandil, Professore presso la Tulane University School of Medicine, che ha formato il Dr. Shahzad Ahmad, endocrinologo e specialista della tiroide proveniente da Salt Lake City.
Durante la sessione, il Dr. Ahmad, Tesoriere della North American Society of Interventional Endocrinology (NASOIE), ha osservato quattro procedure MWA in diretta e ha partecipato a un addestramento pratico. Il programma si è concluso con discussioni sull’implementazione della MWA in diversi contesti clinici e con la consegna di un Certificato di Completamento.
Baird Medical (NASDAQ: BDMD), líder en tecnología de Ablación por Microondas (MWA), organizó una sesión avanzada de entrenamiento MWA en Nueva Orleans. El programa fue dirigido por el Dr. Emad Kandil, Profesor en la Facultad de Medicina de la Universidad de Tulane, capacitando al Dr. Shahzad Ahmad, endocrinólogo y especialista en tiroides de Salt Lake City.
Durante la sesión, el Dr. Ahmad, quien es Tesorero de la Sociedad Norteamericana de Endocrinología Intervencionista (NASOIE), observó cuatro procedimientos MWA en vivo y participó en entrenamiento práctico. El programa finalizó con discusiones sobre la implementación de la MWA en entornos clínicos y la entrega de un Certificado de Finalización.
Baird Medical (NASDAQ: BDMD)는 마이크로웨이브 절제술(MWA) 기술 분야의 선두주자로서 뉴올리언스에서 고급 MWA 교육 세션을 주최했습니다. 이 프로그램은 Tulane University 의과대학의 Emad Kandil 박사가 이끌었으며, 솔트레이크시티 출신의 내분비학자이자 갑상선 전문의인 Shahzad Ahmad 박사를 교육했습니다.
세션 동안 NASOIE(북미 중재 내분비학회) 재무담당인 Ahmad 박사는 네 건의 실시간 MWA 시술을 관찰하고 실습 교육에 참여했습니다. 프로그램은 임상 환경 전반에 MWA를 도입하는 방안에 대한 토론과 수료증 수여로 마무리되었습니다.
Baird Medical (NASDAQ : BDMD), leader dans la technologie d’ablation par micro-ondes (MWA), a organisé une session de formation avancée en MWA à La Nouvelle-Orléans. Le programme a été dirigé par le Dr Emad Kandil, professeur à la Tulane University School of Medicine, qui a formé le Dr Shahzad Ahmad, endocrinologue et spécialiste de la thyroïde originaire de Salt Lake City.
Lors de la session, le Dr Ahmad, trésorier de la North American Society of Interventional Endocrinology (NASOIE), a observé quatre procédures MWA en direct et participé à une formation pratique. Le programme s’est conclu par des discussions sur la mise en œuvre de la MWA en milieu clinique et la remise d’un certificat de réussite.
Baird Medical (NASDAQ: BDMD), ein führendes Unternehmen im Bereich der Mikrowellenablation (MWA)-Technologie, veranstaltete eine fortgeschrittene MWA-Schulung in New Orleans. Das Programm wurde von Dr. Emad Kandil, Professor an der Tulane University School of Medicine, geleitet, der Dr. Shahzad Ahmad, einen Endokrinologen und Schilddrüsenspezialisten aus Salt Lake City, ausbildete.
Während der Sitzung beobachtete Dr. Ahmad, der Schatzmeister der North American Society of Interventional Endocrinology (NASOIE) ist, vier Live-MWA-Verfahren und nahm an praktischen Übungen teil. Das Programm endete mit Diskussionen über die Implementierung von MWA in klinischen Einrichtungen und der Verleihung eines Teilnahmezertifikats.
- None.
- None.
The program, led by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine, provided specialized training to Dr. Shahzad Ahmad, a distinguished endocrinologist and thyroid specialist from
During the training, Dr. Ahmad observed four live MWA procedures, evaluating the technology's efficiency and clinical benefits. Following a hands-on session, he engaged in detailed discussions with Dr. Kandil on implementing MWA across clinical settings. Upon completion, he received a Certificate of Completion, demonstrating his proficiency in this advanced treatment modality.
This initiative reflects Baird Medical's ongoing mission to advance minimally invasive thyroid therapies through collaboration with global medical leaders. By fostering training and knowledge exchange, the company continues to drive innovation and elevate treatment standards worldwide.
About Baird Medical
Baird Medical is a forward-thinking medical device company specializing in minimally invasive diagnostics and treatment. It is dedicated to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments. Our mission is to enhance patient outcomes through precision technology and advanced diagnostic solutions. The company will foster strategic collaborations with leading academic institutions. Our vision extends beyond surgical assistance, aiming to develop intelligent systems that proactively guide diagnostic decisions and preventive healthcare strategies. As an FDA 510(k)-certified medical device company, Baird Medical's solutions have been used in over 30 prestigious hospitals and clinics across
Forward-Looking Statements
This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally relate to future events or Baird Medical's future financial or operating performance. In some cases, you can identify forward-looking statements by terminology such as "may", "could", "should", "expect", "intend", "might", "will", "estimate", "anticipate", "believe", "budget", "forecast", "intend", "plan", "potential", "predict", "potential" or "continue", or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. You should not place undue reliance on forward-looking statements in this press release, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. Baird Medical does not undertake any duty to update these forward-looking statements.
Actual results may vary materially from those expressed or implied by forward-looking statements based on a number of factors, including, without limitation: (1) the risk that Baird Medical may not be successful in expanding its business in China or the
The foregoing list of factors is not exclusive. Additional information concerning certain of these and other risk factors is contained in ExcelFin's most recent filings with the SEC and in the Registration Statement described above filed by Baird Medical in connection with its business combination with ExcelFin. All subsequent written and oral forward-looking statements concerning Baird Medical, the business combination described herein or other matters attributable to Baird Medical or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Baird Medical expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in their expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
Contact:
Eric Huang, PR Liaison
Baird Medical Investment Holdings Ltd.
Phone: +1 (888) 508-6228
Email: ir@bairdmed.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-hosts-advanced-microwave-ablation-training-with-top-thyroid-specialists-302439311.html
SOURCE BDMD
FAQ
What was the purpose of Baird Medical's (BDMD) recent MWA training session in New Orleans?
Who were the key medical professionals involved in BDMD's MWA training program?
What practical experience was included in Baird Medical's MWA training program?
What certification did participants receive after completing BDMD's MWA training?
